Gossamer Bio, Inc.
GOSS· Nasdaq
GOSSGossamer Bio, Inc.
Filed Mar 5, 2024 · 10-K · 65 days after period end · 0001728117-24-000019
derived · Computed from the longer spans the company filed.
| Metric | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures |
|---|---|---|---|---|
| Net Income | -$48.15M | -$55.76M | -$56.28M | -$64.60M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Gossamer Bio, Inc. · CIK 1728117 · Engraved from SEC EDGAR
ended Dec 31, 2023 · filed Mar 5, 2024 · 65 d after period end
